In Vivo Predictive Dissolution and Biopharmaceutic-Based In Silico Model to Explain Bioequivalence Results of Valsartan, a Biopharmaceutics Classification System Class IV Drug
- Gonzalez-Alvarez, I.
- Ruiz-Picazo, A.
- Selles-Talavera, R.
- Figueroa-Campos, A.
- Merino, V.
- Bermejo, M.
- Gonzalez-Alvarez, M.
Zeitschrift:
Pharmaceutics
ISSN: 1999-4923
Datum der Publikation: 2024
Ausgabe: 16
Nummer: 3
Art: Artikel
